A 3-year-old girl from Gujarat with β-thalassemia intermedia presents with severe bone pain and pathological fractures. Radiographs show cortical thinning and generalized osteopenia. What is the most common cause of bone disease in thalassemia patients?

Explanation

## Bone Disease in Thalassemia: Pathophysiology **Key Point:** Extramedullary hematopoiesis and massive bone marrow expansion are the most common cause of bone disease (thalassemic osteodystrophy) in thalassemia patients, particularly in thalassemia intermedia. ### Mechanisms of Bone Pathology in Thalassemia ```mermaid flowchart TD A[Chronic hemolysis + ineffective erythropoiesis]:::outcome --> B[Severe anemia]:::outcome B --> C[Erythropoietin surge]:::action C --> D[Massive bone marrow expansion]:::action D --> E[Cortical thinning and osteopenia]:::outcome D --> F[Pathological fractures]:::outcome D --> G[Bone pain and deformity]:::outcome H[Extramedullary hematopoiesis]:::action --> I[Hepatosplenomegaly, spinal cord compression]:::outcome D -.-> H ``` ### Comparative Pathophysiology of Bone Complications | Mechanism | Prevalence | Severity | Reversibility | Timing | |-----------|-----------|----------|---------------|--------| | **Marrow expansion + EMH** | Most common | Moderate–severe | Partially reversible with transfusion | Early (by age 3–5) | | Iron deposition | Common | Mild–moderate | Irreversible | Late (after age 10) | | Chronic hypoxia | Contributory | Mild | Reversible with transfusion | Variable | | Vitamin D deficiency | Less common | Mild | Reversible with supplementation | Variable | **High-Yield:** Thalassemia intermedia patients have **more severe bone disease** than thalassemia major because they maintain higher hemoglobin levels (less transfusion), leading to **sustained erythropoietin stimulation** and **prolonged marrow expansion**. **Clinical Pearl:** Bone marrow expansion causes: - Cortical thinning and widening of medullary cavity - Pathological fractures (especially vertebrae and femoral neck) - "Chipmunk facies" (frontal bossing, maxillary prominence) - Spinal cord compression from extramedullary hematopoiesis ### Why Iron Deposition Is Secondary While iron deposition in osteoblasts and osteocytes does contribute to bone dysfunction (by impairing osteoblast function and increasing osteoclast activity), it is a **later and less frequent** cause than marrow expansion. Iron-induced bone disease typically manifests after age 10–15 in heavily transfused patients. ### Management Implications - **Transfusion therapy** (in thalassemia intermedia) suppresses EPO and reduces marrow expansion - **Hydroxyurea** (in thalassemia intermedia) increases fetal hemoglobin and reduces hemolysis - **Iron chelation** prevents late iron-induced osteodystrophy - **Calcium and vitamin D supplementation** are adjunctive